Lusutrombopag is a member of cinnamic acids and functions as a thrombopoietin receptor agonist. It is a pharmaceutical raw material used in manufacturing settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1110766-97-6
Ethyl (2E)-3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-2-propenoate
research compound
Eltrombopag Amide
pharmaceutical raw material
Eltrombopag olamine
pharmaceutical raw material
Avatrombopag
pharmaceutical raw material
Avatrombopag maleate
pharmaceutical raw material
Dacomitinib
pharmaceutical raw material
(+)-penicillamine
pharmaceutical raw material
Bromopyruvic acid
pharmaceutical raw material
(E)-3-[2,6-dichloro-4-[[4-[3-[(1S)-1-hexoxyethyl]-2-methoxyphenyl]-1,3-thiazol-2-yl]carbamoyl]phenyl]-2-methylprop-2-enoic acid
NOZIJMHMKORZBA-KJCUYJGMSA-N
CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl